Hebei Jiayuan Network Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hebei Jiayuan Network Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PEILIKENI. The owner is based in Handan City, Hebei.

No. 26 Huancheng West Rd, Congtai Dist

No. 8-1-802, Yufu Tiancheng

Handan City, Hebei 056004 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PEILIKENI
PEILIKENI
Registered 2024

Trademark Classifications

Hebei Jiayuan Network Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Hebei Jiayuan Network Technology Co., Ltd. have?

Hebei Jiayuan Network Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Hebei Jiayuan Network Technology Co., Ltd. file in?

Hebei Jiayuan Network Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Hebei Jiayuan Network Technology Co., Ltd.'s most well-known trademarks?

Hebei Jiayuan Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as PEILIKENI. These are among 1 currently registered trademark in the portfolio.

What is Hebei Jiayuan Network Technology Co., Ltd.'s trademark registration success rate?

Hebei Jiayuan Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.